Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ASO Visual Abstract: Survival Outcomes in Early-Onset Appendiceal Adenocarcinoma (EOAA).

Annals of surgical oncology·2026
Same author

Survival Outcomes in Early Onset Appendiceal Adenocarcinoma (EOAA).

Annals of surgical oncology·2026
Same author

Leading Consortiums from the Ground Up: Leveraging Trainee Collaboration to Create Consensus Guidelines.

Annals of surgical oncology·2026
Same author

Assessing Patient Characteristics in Neuroendocrine Tumor Research: A Comparison of the NET-PRO Study to SEER Population-Based Data.

Endocrine·2026
Same author

ASO Author Reflections: New Insights for Personalized HIPEC Strategies in Colorectal Cancer Peritoneal Metastases.

Annals of surgical oncology·2026
Same author

Using a participation monitoring database to enhance recruitment in a rare cancer population.

Journal of clinical and translational science·2026

Related Experiment Video

Updated: May 11, 2026

Application of the En Bloc Concept Combined with Anatomic Resection in Laparoscopic Hepatectomy
04:41

Application of the En Bloc Concept Combined with Anatomic Resection in Laparoscopic Hepatectomy

Published on: March 10, 2023

Ablation for hepatocellular carcinoma: validating the 3-cm breakpoint.

Ryan T Groeschl1, T Clark Gamblin, Kiran K Turaga

  • 1Division of Surgical Oncology, Department of Surgery, Medical College of WI, Milwaukee, WI, USA. rgroesch@mcw.edu

Annals of Surgical Oncology
|May 31, 2013
PubMed
Summary

The 3-cm cutoff for hepatocellular carcinoma (HCC) ablation is a significant prognostic threshold. Disease-specific survival (DSS) drops notably for tumors larger than 3 cm, suggesting this size is critical for predicting outcomes.

More Related Videos

Three-dimensional Location Approach with Silk Thread Guided Laparoscopic Segmentectomy for Liver Tumor
06:39

Three-dimensional Location Approach with Silk Thread Guided Laparoscopic Segmentectomy for Liver Tumor

Published on: May 23, 2025

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb
04:50

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb

Published on: January 17, 2025

Related Experiment Videos

Last Updated: May 11, 2026

Application of the En Bloc Concept Combined with Anatomic Resection in Laparoscopic Hepatectomy
04:41

Application of the En Bloc Concept Combined with Anatomic Resection in Laparoscopic Hepatectomy

Published on: March 10, 2023

Three-dimensional Location Approach with Silk Thread Guided Laparoscopic Segmentectomy for Liver Tumor
06:39

Three-dimensional Location Approach with Silk Thread Guided Laparoscopic Segmentectomy for Liver Tumor

Published on: May 23, 2025

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb
04:50

Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb

Published on: January 17, 2025

Area of Science:

  • Hepatobiliary Surgery
  • Surgical Oncology
  • Interventional Radiology

Background:

  • Traditional 3-cm cutoff for hepatocellular carcinoma (HCC) ablation outcomes is debated.
  • Growing evidence suggests larger HCC tumors can achieve favorable ablation results.
  • Need to re-evaluate prognostic significance of tumor size thresholds in HCC ablation.

Purpose of the Study:

  • To investigate the prognostic significance of 1-cm tumor size intervals for local ablation in HCC.
  • To challenge the conventional 3-cm cutoff by analyzing disease-specific survival (DSS) across adjacent size groups.
  • To identify critical tumor size thresholds impacting HCC ablation outcomes.

Main Methods:

  • Analysis of Surveillance, Epidemiology, and End Results (SEER) database (2004-2008) for T1 HCC patients treated with local ablation (≤8 cm).
  • Stratification of patients into 1-cm tumor size intervals.
  • Log-rank tests and multivariable Cox proportional hazards models to compare DSS between adjacent groups.

Main Results:

  • A total of 1,083 patients were included (26% female, median age 62).
  • Disease-specific survival (DSS) was significantly lower for 3- to 4-cm tumors compared to 2- to 3-cm tumors (58% vs. 72%, p=0.002).
  • DSS also decreased significantly between 5- to 6-cm and 6- to 7-cm tumors (53% vs. 21%, p=0.006).

Conclusions:

  • The 3-cm tumor size is an important predictive threshold for HCC ablation outcomes.
  • The 6-cm size may also represent a significant threshold impacting disease-specific survival.
  • Future research should consider the 3-cm breakpoint or provide evidence for alternative prognosticators in HCC ablation.